deltatrials

Carcinoma, non-small-cell lung Trials in Limoges, France

Conditions / Carcinoma, non-small-cell lung / Limoges, France

Carcinoma, non-small-cell lung is a medical condition with active clinical research programs worldwide.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID Title Status Phase
NCT04471428 Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy COMPLETED PHASE3
NCT01064050 Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers TERMINATED PHASE4
NCT03053297 Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer) TERMINATED
NCT04487080 A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer ACTIVE_NOT_RECRUITING
NCT01700582 French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings COMPLETED
NCT03030131 Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer TERMINATED PHASE2
NCT06875310 A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) RECRUITING
NCT00535275 NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy TERMINATED PHASE3
NCT00254891 Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer TERMINATED PHASE3
NCT06868277 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer RECRUITING

Related Pages